827 Linden Ave, 2nd Floor University of Maryland Center for Diabetes and Endocrinology
Education and Training
- 2003-2007: M.D.; University of Maryland School of Medicine
- 2007-2010: Residency; Department of Internal Medicine, University of Maryland Medical Center
- 2010-2011: Chief Resident; Department of Internal Medicine, University of Maryland Medical Center
- 2011-2013: Fellowship; Department of Internal Medicine, Division of Endocrinology, Diabetes and Nutrition, University of Maryland Medical Center
Dr. Lamos provides direct patient care as well as teaches medical students, residents, and fellows. The majority of her clinical time is spent treating patients with type 1 and type 2 diabetes mellitus, as well as disorders of the thyroid and pituitary glands. She performs thyroid biopsy and cares for patients with thyroid cancer.
She has a particular interest in clinical research focusing on patient education and practice improvement. She has been an active contributor to medical knowledge through published manuscripts, abstracts, reviews of diabetes and endocrinology topics and textbook chapters. She is core faculty for the Endocrinology fellowship program and enjoys mentoring students, resisdents and fellows at all stages of their careers.
- Lamos EM, Younk LM, Davis SN. Pharmacokinetics and Pharmacodynamics of Insulin Glargine-Insulin Glulisine Basal-Bolus and Twice-Daily Premixed Analog Insulin in Type 1 Diabetes Mellitus Patients during Three Standardized Meals. Journal of Clinical and Translational Endocrinology 2016, Mar;3:14–20.
- Lamos EM. Younk LM, Davis SN. Concentrated insulins: the new basal insulins. Ther Clin Risk Manag 2016, Mar 9;12:389-400.
- Lamos EM, Munir KM. Cushing’s disease: highlighting the importance of early diagnosis for both de novo and recurrent disease in light of evolving treatment patterns. Endo Prac 2014, Sep;20(9):945-55.
Intrusta PM, Lamos E, Galonek HL, Vander Maten, et al. Regulation of apoptosis by viruses that infect insects. Arch Virol Suppl. 2004;(18):171-8.
Lamos EM, Stein SA, Davis SN. Combination glibenclamide-metformin HCl for the treatment of type 2 diabetes. Expert Opinion on Pharmacother. 2012;(17):2545-54.
Stein SA, Lamos EM, Davis SN. A review of the efficacy and safety of oral antidiabetic agents. Expert Opin Drug Saf. 2013; 12(2):153-75.
Lamos EM, Younk LM, Davis SN. Canagliflozin, an inhibitor of sodium glucose co-transporter 2, for the treatment of type 2 diabetes mellitus. Expert Opin On Drug Metab. 2013 Jun;9(6):763-75.
Lamos EM, Stein SA, Davis SN. Sulfonylureas and meglitinides: historical and contemporary issues. Panminerva Medica. 2013; 55(3): 239-251. PMID: 24088798
Konig M, Lamos EM, Stein SA, Davis, SN. An Insight into the Recent Diabetes Trials: What is the Best Approach to Prevent Macrovascular and Microvascular Complications?. Curr Diabetes Rev. 2013; 9(5):371-81.
Stein SA, Lamos EM, Davis SN. Vildagliptin, a Dipeptidyl Peptidase-4 Inhibitor for the Treatment of Type 2 Diabetes. Expert Opin Drug Metab Toxical. 2014 Apr;10(4):599-608.
Lamos EM, Younk LM, Davis, SN. Empagliflozin, a sodium glucose co-transporter 2 inhibitor, in the treatment of type 1 diabetes. Expert Opinion On Investigational Drugs. 2014 Jun;23(6):875-82.
Younk LM, Lamos EM, Davis, SN. Cardiovascular Effects of Insulin. Expert Opin Drug Saf. 2014 Jul;13(7):955-66
Lamos EM, Woodworth GF, Munir KM. Carotid artery aneurysm resulting in myxedema coma. Interdisciplinary Neurosurgery: Advanced Techniques and Case Management. 2 (2015) 120–122.
Croft LD, Liquori M, Ladd J, Day H, Pineles L, Lamos E, Arnold R, Mehrotra P, Fink JC, Langenberg P, Simoni-Wastila L, Perencevich E, Harris AD, Morgan DJ. The effect of contact precautions on frequency of hospital adverse events. Infect Control Hosp Epidemiol. 2015 Nov;36(11):1268-74.
Maria Laarni L. Subang, MD ; Manige Konig, MD2; Paul N. Staats, MD ; Elizabeth M. Lamos, MD ; Kashif M. Munir, MD; Rana Malek, MD. Third Trimester Intraplacental Choriocarcinoma Presenting with Respiratory Failure and Hyperthyroidism. AACE Clinical Case Reports. Vol 2 No. 3 Summer 2016.
Lamos, EM, Levitt D, Munir, KM. A review of dopamine agonist therapy in type 2 diabetes and effects on cardio-metabolic parameters. Prim Care Diabetes. 2016 Feb;10(1):60-5.
Lamos EM, Munir KM. Thyroid swelling and thyroiditis in the setting of recent hCG injections and fine-needle aspiration. Case Rep Endocrinol.2016;2016.
Younk LM, Lamos EM, Davis SN. Cardiovascular effects of anti-diabetes drugs. Expert Opin Drug Saf. 2016 Jun 27:1-19.
Karara, MW, Otieno CF, Okalebo FA, Lamos EM, Kibwage IO. Determinants of insulin-related knowledge among healthcare providers at a county referral hospital in Kenya. Afr. J. Pharmacol. Ther, 2016. Accepted.
Nunez Del Prado SR, Steinman RA, Munir KM, Lamos EM. Supraglottic myxedema:two cases and a review of the literature. AACE Clinical Case Reports, 2016. Accepted.
Lamos EM, Davis SN. Pharmacokinetic evaluation of fixed-ratio combination of insulin degludec and liraglutide in the treatment of type 2 diabetes. Expert Opinion on Drug Metabolism & Toxicology, 2016. Accepted.
Levitt DL, Munir KM, Lamos EM. Dopamine agonist effects on hyperglycemia and the cardiometabolic profile. Internal Medicine Review, 2016. Accepted.
Lamos E, Fairchild E. Endocrinology. In: WolfsthalSD (ed.) National Medical Series Medicine. 7th Edition. Lippincott, Williams and Wilkens, Baltimore, MD. 2011.
Stein S, Lamos E, Quartuccio M, Chandraskaran S, Ionica N, Steinle N. Food Intake and Preference. In: Diet Quality: An Evidence Based Approach, Volume 1. Humana Press, New York, NY, 2013.
Lamos EM, Younk LM, Davis SN. Hypoglycemia. In Endocrine and Metabolic Medical Emergencies. Matfin G (Ed). Endocrine Press, Chevy Chase, MD, 2014.
Davis SN, Lamos EM, Younk LM. Hypoglycemia and Hypoglycemic Syndromes. In Endocrinology: Adult & Pediatric, 7th edition. Degroot LJ and Jameson JL (Eds). Saunders, Philadelphia, PA., 2014.
Sandoval DA, Lamos EM, Younk LM, Davis SN. Hypoglycemia. In Reference Module in Biomedical Sciences. Caplan M and Martini L (Eds). Elsevier, Oxford UK. 2014.
Davis SN, Lamos EM, Loper H, Younk LM. Leptin in Acute Stress. In Leptin - Regulation and Clinical Applications. Dagogo-Jack S (Ed). Springer, New York, NY, 2015.